Announce Date | 07/31/2025 |
EPS Normalized Actual | $4.43 (Beat by $0.22) |
EPS GAAP Actual | $4.43 (Beat by $0.22) |
Revenue Actual | $3.755B |
Revenue Surprise | Beat by $3755M |
Announce Date | 10/01/2025 (Pre-Market) |
EPS Normalized Estimate | $3.97245 |
EPS GAAP Estimate | $3.97245 |
Revenue Estimate | $3.576698611B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 24.75 | 19.64 | 23.79107 | 25.29904 | 1 |
Dec 2028 | 21.4 | 22.71 | 21.04331 | 21.70509 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 3.5 | 3.5 | 3.755B | 5.49% | 3755M |
FQ1 2025 (Mar 2025) | 3.55 | 3.55 | 3.777B | 7.57% | 3777M |
FQ4 2024 (Dec 2024) | 0 | 0 | 3.592B | 100% | 3592M |
FQ3 2024 (Sep 2024) | 3.12 | 3.12 | 3.575B | 13.73% | 3575M |
FQ2 2024 (Jun 2024) | 3.23 | 3.23 | 3.549B | 12.62% | 3549M |
FQ1 2024 (Mar 2024) | 3.16 | 3.16 | 3.491B | 15.87% | 3491M |
FQ3 2023 (Sep 2023) | 2.34 | 2.34 | 3.084B | 7.23% | 3084M |
FQ2 2023 (Jun 2023) | 1.6 | 1.6 | 3.101B | 100% | 3101M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
3.97245
Consensus Revenue Estimates
3.576698611B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 4.9949 | -- | 4.9949 | 4.9949 | 5 |
FQ3 2027 (Jul 2027) | 4.8097 | -- | 4.8097 | 4.8097 | 5 |
FQ2 2027 (Jun 2027) | 4.6047 | -- | 4.51706 | 4.73351 | 5 |
FQ1 2027 (Mar 2027) | 4.6708 | -- | 4.5819 | 4.80146 | 5 |
FQ4 2026 (Oct 2026) | 4.4089 | -- | 4.10245 | 4.53253 | 5 |
FQ3 2026 (Jul 2026) | 4.2962 | -- | 3.99758 | 4.41667 | 5 |
FQ2 2026 (Jun 2026) | 4.2624 | 17.89 | 4.20897 | 4.35165 | 9 |
FQ1 2026 (Mar 2026) | 4.1284 | 14.01 | 4.07665 | 4.21484 | 9 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 6.1B | -- | 6.1B | 6.1B | 6 |
FQ3 2027 (Jul 2027) | 5.86B | -- | 5.86B | 5.86B | 6 |
FQ2 2027 (Jun 2027) | 5.72B | -- | 5.64B | 5.85B | 6 |
FQ1 2027 (Mar 2027) | 5.5B | -- | 5.42B | 5.62B | 6 |
FQ4 2026 (Oct 2026) | 3.71B | -- | 3.52B | 3.79B | 10 |
FQ3 2026 (Jul 2026) | 3.68B | -- | 3.49B | 3.76B | 10 |
FQ2 2026 (Jun 2026) | 3.6B | -4.22 | 3.57B | 3.66B | 10 |
FQ1 2026 (Mar 2026) | 3.65B | -3.58 | 3.61B | 3.71B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 3.5 | 3.5 | 100% | |
FQ1 2025 (Mar 2025) | 3.55 | 3.55 | 100% | |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 3.12 | 3.12 | 100% | |
FQ2 2024 (Jun 2024) | 3.23 | 3.23 | 100% | |
FQ1 2024 (Mar 2024) | 3.16 | 3.16 | 100% | |
FQ3 2023 (Sep 2023) | 2.34 | 2.34 | 100% | |
FQ2 2023 (Jun 2023) | 1.6 | 1.6 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $3.76B | $3755M | 100% |
FQ1 2025 (Mar 2025) | $0B | $3.78B | $3777M | 100% |
FQ4 2024 (Dec 2024) | $0B | $3.59B | $3592M | 100% |
FQ3 2024 (Sep 2024) | $0B | $3.58B | $3575M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.55B | $3549M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.49B | $3491M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.08B | $3084M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.1B | $3101M | 100% |